These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 28828589

  • 1. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P, Evangelista L, Caobelli F, Spallino M, Gianolli L, Midiri M, Picchio M.
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [Abstract] [Full Text] [Related]

  • 2. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
    Alongi P, Caobelli F, Gentile R, Stefano A, Russo G, Albano D, Baldari S, Gilardi MC, Midiri M.
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154
    [Abstract] [Full Text] [Related]

  • 3. Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma.
    Albano D, Familiari D, Fornito MC, Scalisi S, Laudicella R, Galia M, Grassedonio E, Ruggeri A, Ganduscio G, Messina M, Spada M, Midiri M, Alongi P.
    Curr Radiopharm; 2020 Feb; 13(1):42-47. PubMed ID: 31595860
    [Abstract] [Full Text] [Related]

  • 4. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
    Alongi P, Picchio M, Zattoni F, Spallino M, Gianolli L, Saladini G, Evangelista L.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
    Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
    [Abstract] [Full Text] [Related]

  • 6. Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma.
    Albano D, Zizioli V, Odicino F, Giubbini R, Bertagna F.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Mar; 38(2):87-93. PubMed ID: 30573388
    [Abstract] [Full Text] [Related]

  • 7. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
    Albano D, Familiari D, Gentile R, Scalisi S, Midiri F, Messina M, Spada M, Fornito MC, Galia M, Midiri M, Alongi P.
    Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and prognostic 18F-FDG PET/CT role in recurrent vulvar cancer: a multicentric experience.
    Albano D, Bonacina M, Savelli G, Ferro P, Busnardo E, Gianolli L, Camoni L, Giubbini R, Bertagna F.
    Jpn J Radiol; 2022 Jan; 40(1):66-74. PubMed ID: 34272721
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification.
    Cochet A, David S, Moodie K, Drummond E, Dutu G, MacManus M, Chua B, Hicks RJ.
    Cancer Imaging; 2014 Apr 22; 14(1):13. PubMed ID: 25608599
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma.
    Jreige M, Mitsakis P, Van Der Gucht A, Pomoni A, Silva-Monteiro M, Gnesin S, Boubaker A, Nicod-Lalonde M, Duran R, Prior JO, Denys A, Schaefer N.
    Eur J Nucl Med Mol Imaging; 2017 Jul 22; 44(7):1215-1222. PubMed ID: 28233086
    [Abstract] [Full Text] [Related]

  • 17. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
    Rasheed R, Al-Kandari F, Ghanem M, Marafi F, Usmani S.
    Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):511-515. PubMed ID: 32102532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.